Westhampton Capital
BMY icon

Westhampton Capital’s Bristol-Myers Squibb BMY Stock Holding History

Westhampton Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.52M Sell
24,322
-400
-2% -$25.3K 0.67% 43
2026
Q2 		$1.42M Sell
24,722
-400
-2% -$23K 0.59% 49
2026
Q1 		$1.52M Sell
25,122
-300
-1% -$17.5K 0.71% 42
2025
Q4 		$1.37M Buy
25,422
+605
+2% +$29.1K 0.65% 51
2025
Q3 		$1.12M Buy
24,817
+400
+2% +$18.7K 0.55% 55
2025
Q2 		$1.13M Sell
24,417
-1,000
-4% -$49.1K 0.58% 55
2025
Q1 		$1.55M Sell
25,417
-2,000
-7% -$117K 0.85% 42
2024
Q4 		$1.55M Buy
27,417
+200
+0.7% +$11.2K 0.79% 43
2024
Q3 		$1.41M Buy
27,217
+11,700
+75% +$549K 0.71% 48
2024
Q2 		$644K Buy
15,517
+5,850
+61% +$262K 0.35% 77
2024
Q1 		$541K Buy
9,667
+3,745
+63% +$191K 0.3% 84
2023
Q4 		$304K Sell
5,922
-8,020
-58% -$421K 0.18% 101
2023
Q3 		$809K Hold
13,942
– – 0.52% 61
2023
Q2 		$892K Hold
13,942
– – 0.58% 54
2023
Q1 		$966K Hold
13,942
– – 0.62% 55
2022
Q4 		$1M Sell
13,942
-70
-0.5% -$5.28K 0.68% 54
2022
Q3 		$996K Sell
14,012
-300
-2% -$21.8K 0.75% 50
2022
Q2 		$1.1M Hold
14,312
– – 0.78% 46
2022
Q1 		$1.04M Sell
14,312
-200
-1% -$13.4K 0.67% 49
2021
Q4 		$905K Hold
14,512
– – 0.55% 55
2021
Q3 		$859K Sell
14,512
-2,600
-15% -$171K 0.59% 54
2021
Q2 		$1.14M Sell
17,112
-100
-0.6% -$6.52K 0.74% 47
2021
Q1 		$1.09M Buy
17,212
+1,000
+6% +$62.2K 0.75% 43
2020
Q4 		$1.01M Sell
16,212
-200
-1% -$12.3K 0.75% 45
2020
Q3 		$989K Sell
16,412
-130
-0.8% -$7.82K 0.81% 42
2020
Q2 		$973K Buy
16,542
+300
+2% +$17.9K 0.85% 40
2020
Q1 		$905K Sell
16,242
-235
-1% -$14.4K 0.94% 35
2019
Q4 		$1.06M Buy
16,477
+7,650
+87% +$438K 0.86% 38
2019
Q3 		$448K Buy
8,827
+780
+10% +$36.7K 0.37% 71
2019
Q2 		$365K Buy
+8,047
New +$375K 0.31% 80

Other funds holding BMY

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Westhampton Capital's BMY Position: Q3 2026 in Review

Westhampton Capital reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q3 2026, selling an estimated $25.3K and leaving 24,322 shares worth $1.52M. The position accounts for 0.67% of the portfolio, ranked #43.

Westhampton Capital first reported a position in BMY in Q2 2019 and has held it in 30 quarters since. The position peaked at $1.55M in Q4 2024. 1,171 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Westhampton Capital held 24,322 shares of Bristol-Myers Squibb worth $1.52M as of Q3 2026.
  • Westhampton Capital sold 400 Bristol-Myers Squibb shares in Q3 2026, an estimated $25.3K.
  • Bristol-Myers Squibb made up 0.67% of Westhampton Capital's portfolio in Q3 2026, its #43 holding.
  • Westhampton Capital first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 30 quarters since.
  • Westhampton Capital's Bristol-Myers Squibb position peaked at $1.55M in Q4 2024.
  • 1,171 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Westhampton Capital's 13F filing for Q3 2026, filed 30 Oct 2026.